Home > Specialties > IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, GPC3

IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, GPC3

Definition : Molecular assay reagents intended to identify mutations in the glypican 3 (GPC3) gene, located at chromosome Xq26.1, which may be involved in the suppression or modulation of growth in tissue and organs of mesodermal origin and may also regulate growth and tumor predisposition. Mutations at this locus have been identified in patients with encephalo-tropho-schisis syndrome, also known as Simpson-Golabi-Behmel syndrome type 1.

Entry Terms : "Simpson-Golabi-Behmel Syndrome Type 1 Gene Mutation Detection Reagents" , "X-Linked Encephalo-Tropho-Schisis Gene Mutation Detection Reagents" , "Encephalo-Tropho-Schisis Gene Mutation Detection Reagents" , "GPC3 GEne Mutation Detection Reagents" , "Reagents, Molecular Assay, Gene Anomaly, Mutation, GPC3"

UMDC code : 24451

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-3 of 3 Match(es).

ACROBiosystems Inc

Company Type: Parent

BioMosaics Inc

Company Type: Parent

Cancer Diagnostics Inc

Company Type: Parent

Cancer Diagnostics, Inc. (CDI)  manufactures, develops, and supplies products for the worldwide anatomical pathology market.

1-3 of 3 Match(es).

 

Medical Product Guide Optometric Management Product Guide